Monophase HA / Deep
Crosslinked HA Dermal Filler - Deep 1ml
- Concentration
- 25mg/ml
- Material / Composition
- 100% pure HA
- Volume / Specification
- 1ml / 2ml / 10ml / 20ml
Sub-skin Injectable HA Gel with Lidocaine 1ml
Legacy sub-skin product
- Concentration
- 24mg/ml
- Material / Composition
- Crosslinked HA
- Volume / Specification
- 1.0ml
- Package format
- 1 syringe HA gel
- OEM / private label available
- Specification sheet on request
- Quality management system scope applies
Full specifications for procurement
| Product name | Sub-skin #1 Injectable HA Gel With Lido |
|---|---|
| Brand | 히야론동국앵미® |
| Model / Type | Sub-skin #1 |
| Technology | Crosslinked HA injectable filler with lido |
| Material / Composition | Crosslinked HA |
| Concentration | 24mg/ml |
| Volume / Specification | 1.0ml |
| Package format | 1 syringe HA gel |
| Shelf life | 24 months |
| Storage | Room temperature; shade; do not refrigerate |
| Intended use | Chin / cheek augmentation |
| Available variants | Legacy Sub-skin series |
Intended use
Chin / cheek augmentation
Documentation & compliance
The products in this family fall within the manufacturing scope stated on the quality management system certificates below. A quality management system certificate is not a product registration or market authorisation.
- GB/T 42061-2022 04725Q10000111
- GB/T 19001-2016 04725Q10111R1S
Related products
Explore the range
HA Filler / Deep
Deep Crosslinked HA Facial Shaper 1ml
- Concentration
- 24mg/ml
- Material / Composition
- 100% pure HA
- Volume / Specification
- 1ml / 2ml / 10ml / 20ml / 50ml
HA Filler / Deep
OEM Dermal Filler HA Gel 2ml
- Concentration
- 25mg/ml
- Material / Composition
- 100% pure HA
- Volume / Specification
- 2ml
Legacy HA / Deep
DEEP #1 Injectable HA Gel With Lido
- Concentration
- 24mg/ml
- Material / Composition
- Crosslinked HA
- Volume / Specification
- 1.0ml
Request for quotation
Request a quotation for this product
Direct response with technical specifications, tiered quotation and country-specific documentation status.